Fig. 7From: Investigate the mechanisms of Chinese medicine Fuzhengkangai towards EGFR mutation-positive lung adenocarcinomas by network pharmacologyThe binding sites of PRKCA and BCL2. a Three-dimension structure of PRKCA. b Three-dimension structures of BCL2. The proteins are shown in green cartoon and the co-crystalized inhibitors are shown in orange sticksBack to article page